emodin and purpurin

emodin has been researched along with purpurin in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (33.33)24.3611
2020's2 (66.67)2.80

Authors

AuthorsStudies
Dutour, R; Poirier, D1
Inui, K; Kanamitsu, K; Katayama, W; Kitakami, R; Mizuguchi, M; Nakagawa, S; Nakagawa, Y; Okada, T; Sawai, Y; Toyooka, N; Yokoyama, T1
Lefin, R; Petzer, A; Petzer, JP1

Reviews

1 review(s) available for emodin and purpurin

ArticleYear
Inhibitors of cytochrome P450 (CYP) 1B1.
    European journal of medicinal chemistry, 2017, Jul-28, Volume: 135

    Topics: Cytochrome P-450 CYP1B1; Cytochrome P-450 Enzyme Inhibitors; Dose-Response Relationship, Drug; Humans; Molecular Structure; Structure-Activity Relationship

2017

Other Studies

2 other study(ies) available for emodin and purpurin

ArticleYear
Inhibitory activities of anthraquinone and xanthone derivatives against transthyretin amyloidogenesis.
    Bioorganic & medicinal chemistry, 2021, 08-15, Volume: 44

    Topics: Amyloid Neuropathies, Familial; Anthraquinones; Crystallography, X-Ray; Dose-Response Relationship, Drug; Humans; Models, Molecular; Molecular Structure; Structure-Activity Relationship; Xanthones

2021
Phenothiazine, anthraquinone and related tricyclic derivatives as inhibitors of monoamine oxidase.
    Bioorganic & medicinal chemistry, 2022, 01-15, Volume: 54

    Topics: Anthraquinones; Dose-Response Relationship, Drug; Humans; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Phenothiazines; Structure-Activity Relationship

2022